Biblio
2023
Li VWK, Yim R, Lee P, Chin L, Au L, Leung GMK, Sim J, Lie AKW, Tse E, Kwong Y-L, et al. Allogeneic haematopoietic stem cell transplantation for myelofibrosis: prognostic indicators and the role of JAK2V617F measurable-residual disease monitoring by droplet-digital polymerase chain reaction. Ann Hematol. 2023.
Gill H, Leung GMK, Ooi MGM, Z Y Teo W, Wong C-L, Choi CWon, Wong G-C, Lao Z, Rojnuckarin P, Castillo MRosario Ir, et al. Management of classical Philadelphia chromosome-negative myeloproliferative neoplasms in Asia: consensus of the Asian Myeloid Working Group. Clin Exp Med. 2023.
2020
Gill H, Yim R, Pang HH, Lee P, S Y Chan T, Hwang Y-Y, Leung GMK, Ip H-W, Y Y Leung R, Yip S-F, et al. Clofarabine, cytarabine, and mitoxantrone in refractory/relapsed acute myeloid leukemia: High response rates and effective bridge to allogeneic hematopoietic stem cell transplantation. Cancer Med. 2020.
2019
Leung GMK, Zhang C, Ng NKL, Yang N, S Y Lam S, Au CH, Chan TL, Ma ESK, Tsui SP, Ip HW, et al. Distinct mutation spectrum, clinical outcome and therapeutic responses of typical complex/monosomy karyotype acute myeloid leukemia carrying TP53 mutations. Am J Hematol. 2019.
Zhang C, S Y Lam S, Leung GMK, Tsui S-P, Yang N, Ng NKL, Ip H-W, Au C-H, Chan T-L, Ma ESK, et al. Sorafenib and omacetaxine mepesuccinate as a safe and effective treatment for acute myeloid leukemia carrying internal tandem duplication of Fms-like tyrosine kinase 3. Cancer. 2019.